Results 111 to 120 of about 40,178 (264)
Aims NFE2L2 encodes the transcription factor, NRF2, which is a regulator of cellular oxidative stress responses and metabolic homeostasis. NFE2L2 alterations are implicated in multiple cancers, with significant study in thoracic oncology, with an adverse prognosis, aggressive behaviour, metabolic reprogramming and diminished responses to chemotherapy ...
Dane Wuori +5 more
wiley +1 more source
What’s known on the subject? and What does the study add?:It is known that the lymph node yield in open cystectomy is variable and dependent, in some part, upon surgeon experience.This study, the largest of its kind reporting on outcomes associated with ...
Lee Richstone +48 more
core +1 more source
Jisun Lee, Juyeon Kang, Hyun Jung Lee Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of KoreaCorrespondence: Hyun Jung Lee, Department of Obstetrics and ...
Lee J, Kang J, Lee HJ
doaj
The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
Abstract Background Acquired hypofibrinogenemia poses significant bleeding risks. Concentrated sources of fibrinogen, whether cryoprecipitate or fibrinogen concentrates, are widely used. This scoping review aimed to identify and map the available evidence on fibrinogen supplementation.
Aaron S. Hess +15 more
wiley +1 more source
Use of MRI in the diagnosis of bladder cancer: a health economic analysis
BJU International, EarlyView.
Niranjan Sathianathen +4 more
wiley +1 more source
Abstract Background Monitoring Patient Blood Management (PBM) practices against evidence‐based standards is essential for quality improvement; however, current approaches are limited. In the UK, perioperative tranexamic acid (TXA) use is a national quality standard, yet monitoring relies on manual audit cycles that are resource‐intensive and limited in
Muhammad Naim Che Rahimi +7 more
wiley +1 more source
Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
Background Neoadjuvant platinum‐based chemotherapy offers a modest survival advantage in muscle‐invasive bladder cancer (MIBC) for patients with pathologic response.
Ekamjit S. Deol +8 more
doaj +1 more source
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen +15 more
wiley +1 more source
Among the many milestones in the last several decades in the management of muscle-invasive bladder cancer and high-risk nonmuscle-invasive bladder cancer including the extension of the standard lymph node dissection and the use of neoadjuvant ...
Marissa Kent +3 more
core +1 more source

